about
Botulinum toxin injections for treating neurogenic detrusor overactivityAccreditation of medical education and urology: An interview with Prof. Iskender Sayek, President of Association for Evaluation and Accreditation of Medical Education Programs (TEPDAD).Metabolic syndrome does not impair the response to alfuzosin treatment in men with lower urinary tract symptoms: a double-blind, randomized, placebo-controlled studyRole of percutaneous posterior tibial nerve stimulation either alone or combined with an anticholinergic agent in treating patients with overactive bladderThe attitudes of Urologists and Gynecologists about overactive bladder and treatment of it in Turkey: A questionnaire survey.Efficacy and safety of onabotulinumtoxinA injection in patients with refractory overactive bladder: First multicentric study in Turkish population.A novel false-positive cause in testis scintigraphy in the diagnosis of testis torsion.Re: Family compliance with the use of alarm devices in the treatment of monosymptomatic nocturnal enuresis.Re: The relationships between metabolic syndrome, erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia.The effects of melatonin and the antioxidant defence system on apoptosis regulator proteins (Bax and Bcl-2) in experimentally induced varicocele.The inhibitory role of melatonin on isolated guinea-pig urinary bladder: an endogenous hormone effect.Editorial comment on: transobturator sling suspension for male urinary incontinence including post-radical prostatectomy.Evaluation of sexual function in women at two stages of multiple sclerosis.Patient satisfaction and clinical efficacy of the new perineal bone-anchored male sling.Prevalence and risk factors of female urinary incontinence in eastern Turkey.New perineal bone-anchored male sling: lessons learned.Measuring resistance index in patients with BPH and lower urinary tract symptoms.Incidence of bacteraemia after urodynamic study.Role of tissue polypeptide specific antigen in the detection of prostate cancer.Behçet's disease and spontaneous haematocele: an unusual complicationIncreased discrimination between benign prostatic hyperplasia and prostate cancer with equimolar total prostate specific antigen measurementInfertility treatment in autosomal dominant polycystic kidney disease (ADPKD)--a case reportSeminal plasma cytokine levels in the diagnosis of chronic pelvic pain syndromePenile amputation in Buerger's disease-an unusual cause of organ lossContemporary impact of transrectal ultrasound lesions for prostate cancer detectionComparison of two different microsurgical methods in the treatment of varicoceleSecondary ejaculatory duct obstruction: management by secondary transurethral resection of ejaculatory ductComparison of solvent-dehydrated allograft dermis and autograft rectus fascia for pubovaginal sling: questionnaire-based analysisTechnetium Tc 99m sulphur colloid seminal vesicle scintigraphy: a novel approach for the diagnosis of the ejaculatory duct obstructionSolvent-dehydrated cadaveric dermis: a new allograft for pubovaginal sling surgeryIn vitro examination of effects of hyperprolactinemia and hypoprolactinemia on seminal vesicle contractionsSingle-incision midurethral sling shows less pain and similar success rate in a short-term follow-up compared to the transobturator tape method in the treatment of stress urinary incontinence
P50
Q26775670-6A5A2618-9202-4D08-B0B5-4B9F471B0817Q35994000-D93B3D85-E1A2-418D-8209-C481752D8786Q36170066-AE9A977D-1298-434A-A04A-241AC88F290DQ36208247-A93AFCF7-1ECD-4140-96B5-6DC433ECE2F2Q37671608-DA9B7BB8-B0C1-4694-B1EC-0AD1CBA5FAE8Q40252069-0AC2731C-93CF-4F3D-91A4-1EAF6522532EQ42105104-CE6F5309-0DD0-4D15-8363-A2554D877F51Q42813486-AD7C963F-8014-4544-8FD2-FCF4EFC6812AQ42816520-4A1C5C21-19F4-4B46-A2B3-6B0126B257C1Q44943112-6AF5C5A0-6ED9-4D75-8D70-86E91520B865Q45194940-242510D4-214B-499C-8E6B-411D647D72CEQ51062494-D52A39D1-36FC-4C1A-A639-BB82289C880BQ51334121-1FB92E46-47C2-43CF-85BF-6436317BCC3AQ51551011-F034D61C-13DD-4D77-9D2B-85FAA3CF2406Q51637555-921514ED-C2AB-4BC2-87C2-AB59E854C691Q51649161-B2072E3C-6FD5-4786-885F-D01EC76A1543Q53859524-D41A1393-5AF4-463F-8B55-8DD9DE0FD347Q54503540-34EEC71A-AFC8-4A42-A4D7-58EB0CF5E30EQ64980430-1D24A274-2C60-4276-91A0-C857D11EB3BFQ73049997-436A72D6-2822-4810-B683-6A2B6D155E46Q73413966-CC69AEBA-32C2-4254-BBA1-2DE26873D279Q73647641-C5FE1DE5-CADF-4833-BB32-6BDA97DBA9FAQ77086524-AB83F10F-2B70-496A-A793-612680771FCCQ80215590-8CDE68D8-FC73-4DCB-B760-52263141D99EQ80328263-DBF45745-6B7F-449B-9EEC-CB26F304C003Q80386980-0CA7BE7F-4F78-4434-80F3-92C6724E3A6BQ80386983-44E7E9C1-7CD8-481E-BC3E-204E5B716126Q80565495-23658A7E-A5DF-4F12-8437-C0F5125D0F3CQ80803831-C561311F-6A1B-439C-A8B1-AE0F7E87C170Q81303857-10EBD9FE-A24E-4EC9-BB04-8577C6041EEFQ85960987-99A1A80E-82C2-4DF6-841F-FAE278C48BC4Q90969625-A1D7BF23-3463-447F-B931-7216484EEFFB
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rahmi Onur
@ast
Rahmi Onur
@en
Rahmi Onur
@es
Rahmi Onur
@nl
Rahmi Onur
@sl
type
label
Rahmi Onur
@ast
Rahmi Onur
@en
Rahmi Onur
@es
Rahmi Onur
@nl
Rahmi Onur
@sl
prefLabel
Rahmi Onur
@ast
Rahmi Onur
@en
Rahmi Onur
@es
Rahmi Onur
@nl
Rahmi Onur
@sl
P106
P31
P496
0000-0001-6235-0389